Aspirin attenuates angiotensin II-induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF-κB activation
about
A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction.Modulatory effect of silymarin on pulmonary vascular dysfunction through HIF-1α-iNOS following rat lung ischemia-reperfusion injuryProtective effects of resveratrol on osteoporosis via activation of the SIRT1-NF-κB signaling pathway in rats.Lipopolysaccharide can modify differentiation and immunomodulatory potential of periodontal ligament stem cells via ERK1,2 signaling.Pterostilbene protects against acute renal ischemia reperfusion injury and inhibits oxidative stress, inducible nitric oxide synthase expression and inflammation in rats via the Toll-like receptor 4/nuclear factor-κB signaling pathway.The Influence of AGEs Environment on Proliferation, Apoptosis, Homeostasis, and Endothelial Cell Differentiation of Human Adipose Stem Cells.Aspirin modulates the inflammatory response in a thrombus‑stimulated LMVEC model.
P2860
Q37683865-3024FA9A-C6E0-4D8A-9685-B2624422E2D0Q42413536-6F814A2D-E06C-45DB-B2DB-AC76BBEB8222Q47164485-7AF8F805-A821-40E6-AF8E-837A5E7EE0C1Q47335104-13342DC2-0452-40B4-8971-B6A51CB52380Q49294301-CF54FDE4-4506-40AF-ADAA-8FC70A960F30Q50905152-0E015947-296F-4750-8700-5582369D1C69Q52641302-079E8627-7CF7-46A0-BF99-8A7430C7E80F
P2860
Aspirin attenuates angiotensin II-induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF-κB activation
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Aspirin attenuates angiotensin ...... of ERK1/2 and NF-κB activation
@en
type
label
Aspirin attenuates angiotensin ...... of ERK1/2 and NF-κB activation
@en
prefLabel
Aspirin attenuates angiotensin ...... of ERK1/2 and NF-κB activation
@en
P2093
P2860
P356
P1433
P1476
Aspirin attenuates angiotensin ...... of ERK1/2 and NF-κB activation
@en
P2093
Fenxi Zhang
Huaibin Wang
Tongming Ren
P2860
P304
P356
10.3892/BR.2013.160
P577
2013-08-23T00:00:00Z